List of Excipients in API mepivacaine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mepivacaine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Hospira Inc | CARBOCAINE | mepivacaine hydrochloride | 0409-1036 | CALCIUM CHLORIDE | |
| Hospira Inc | CARBOCAINE | mepivacaine hydrochloride | 0409-1036 | HYDROCHLORIC ACID | |
| Hospira Inc | CARBOCAINE | mepivacaine hydrochloride | 0409-1036 | POTASSIUM CHLORIDE | |
| Hospira Inc | CARBOCAINE | mepivacaine hydrochloride | 0409-1036 | SODIUM CHLORIDE | |
| Hospira Inc | CARBOCAINE | mepivacaine hydrochloride | 0409-1036 | SODIUM HYDROXIDE | |
| Hospira Inc | CARBOCAINE | mepivacaine hydrochloride | 0409-1036 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing mepivacaine hydrochloride
Detailed excipient profiles for mepivacaine hydrochloride
Excipient focus: CALCIUM CHLORIDE
mepivacaine hydrochloride drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | mepivacaine hydrochloride | 0409-1036 |
| >Company | >Ingredient | >NDC |
mepivacaine hydrochloride drug variants not containing CALCIUM CHLORIDE
Excipient focus: EDETATE DISODIUM
mepivacaine hydrochloride drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | mepivacaine hydrochloride and levonordefrin | 0362-0931 |
| Septodont Inc | mepivacaine hydrochloride and levonordefrin | 0362-1097 |
| Novocol Pharmaceutical of Canada Inc | mepivacaine hydrochloride and levonordefrin | 51004-1097 |
| >Company | >Ingredient | >NDC |
mepivacaine hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
mepivacaine hydrochloride drug variants containing HYDROCHLORIC ACID
mepivacaine hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: METHYLPARABEN
mepivacaine hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | mepivacaine hydrochloride | 50090-4408 |
| A-S Medication Solutions | mepivacaine hydrochloride | 50090-4517 |
| Fresenius Kabi USA LLC | mepivacaine hydrochloride | 63323-283 |
| >Company | >Ingredient | >NDC |
mepivacaine hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: POTASSIUM CHLORIDE
mepivacaine hydrochloride drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | mepivacaine hydrochloride | 0409-1036 |
| >Company | >Ingredient | >NDC |
mepivacaine hydrochloride drug variants not containing POTASSIUM CHLORIDE
Excipient focus: POTASSIUM METABISULFITE
mepivacaine hydrochloride drug variants containing POTASSIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | mepivacaine hydrochloride and levonordefrin | 0362-0931 |
| Septodont Inc | mepivacaine hydrochloride and levonordefrin | 0362-1097 |
| Novocol Pharmaceutical of Canada Inc | mepivacaine hydrochloride and levonordefrin | 51004-1097 |
| >Company | >Ingredient | >NDC |
mepivacaine hydrochloride drug variants not containing POTASSIUM METABISULFITE
Excipient focus: SODIUM CHLORIDE
mepivacaine hydrochloride drug variants containing SODIUM CHLORIDE
mepivacaine hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
mepivacaine hydrochloride drug variants containing SODIUM HYDROXIDE
mepivacaine hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: WATER
mepivacaine hydrochloride drug variants containing WATER
mepivacaine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | mepivacaine hydrochloride | 50090-4408 |
| A-S Medication Solutions | mepivacaine hydrochloride | 50090-4517 |
| Fresenius Kabi USA LLC | mepivacaine hydrochloride | 63323-283 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
